Your session is about to expire
← Back to Search
Episodic Future Thinking for Type 2 Diabetes
N/A
Recruiting
Led By Jeffrey Stein, PhD
Research Sponsored by Virginia Polytechnic Institute and State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 24
Awards & highlights
Study Summary
This trial will compare the effects of episodic future thinking (EFT) on delaying discounting in adults with type 2 diabetes.
Who is the study for?
This trial is for adults with type 2 diabetes who live in urban or rural areas, have an HbA1c level of at least 7.7%, and a body mass index (BMI) of 30 or higher. It's not suitable for those with intellectual impairments, gestational diabetes, pregnant or lactating women, non-ambulatory individuals, or unmanaged psychiatric conditions.Check my eligibility
What is being tested?
The study tests if 'Episodic Future Thinking'—imagining future events to influence present decisions—can help manage type 2 diabetes better than 'Healthy Information Thinking'. Participants are randomly assigned to one of these two groups and followed over a period of 24 weeks.See study design
What are the potential side effects?
Since the interventions involve psychological strategies rather than medications, traditional side effects like you'd see with drugs aren't expected. However, participants may experience emotional discomfort when engaging in these thinking exercises.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ week 24
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 24
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in body mass index from baseline (Week 0) to Week 24
Change in body mass index from baseline (Week 0) to Week 8
Change in glycemic control from baseline (Week 0) to Week 24
+1 moreSecondary outcome measures
Change in dietary intake from baseline (Week 0) to Week 24
Change in dietary intake from baseline (Week 0) to Week 8
Change in physical activity from baseline (Week 0) to Week 24
+4 moreOther outcome measures
Change in delay discounting from baseline (Week 0) to Week 24
Change in delay discounting from baseline (Week 0) to Week 8
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Episodic Future ThinkingExperimental Treatment1 Intervention
Participants will generate vivid, episodic events and be prompted via a guided smartphone app to engage in EFT in their daily lives. EFT will be paired with diet and physical activity support.
Group II: Healthy Information ThinkingActive Control1 Intervention
Participants will be prompted via a guided smartphone app to thinking about their written responses to informational health vignettes during their daily lives. The HIT condition will be paired with diet and physical activity support.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Episodic Future Thinking
2018
N/A
~450
Find a Location
Who is running the clinical trial?
Virginia Polytechnic Institute and State UniversityLead Sponsor
142 Previous Clinical Trials
27,637 Total Patients Enrolled
Carilion ClinicOTHER
71 Previous Clinical Trials
12,586 Total Patients Enrolled
University at BuffaloOTHER
132 Previous Clinical Trials
98,859 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I cannot walk on my own.I have an intellectual disability.You are very overweight.You are currently diagnosed with gestational diabetes.You live in a city or countryside.Your HbA1c level is 7.7% or higher.I do not have any untreated mental health conditions.
Research Study Groups:
This trial has the following groups:- Group 1: Episodic Future Thinking
- Group 2: Healthy Information Thinking
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What are the fundamental goals of this research project?
"This clinical trial will measure the principal objective of glycemic control from baseline to Week 8. Secondary objectives include a Change in self-reported adherence to glucose-lowering medication up until Week 24, and an evaluation of dietary intake between Baseline and Week 8 using ASA-24 online food recalls; participants will also rate their perceived ease of use and effectiveness through a Likert scale."
Answered by AI
How many individuals are currently involved in this research project?
"Affirmative. Evidence on clinicaltrials.gov reveals that, since being posted on July 20th 2022 and having its most recent update November 21st 2022, this scholarly investigation is currently looking for 120 volunteers from a single medical establishment."
Answered by AI
Are there vacancies for any more participants in this experiment?
"As per clinicaltrials.gov, this research is currently recruiting participants. It was first listed on July 20th 2022 and amended most recently on November 21st of the same year."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger